EUVIMED · CrossrefZeitschrift
Best Practice & Research Clinical Haematology
ISSN 1521-6926 · Elsevier BV
Neueste Artikel
Advances in NK cell therapy for multiple myeloma
Immune reconstitution following allogeneic hematopoietic cell transplantation and CAR-T therapy: dynamics, determinants, and directions
Creating a GMP cell processing program: A focus on quality and regulation
Cytokine therapy of acute radiation syndrome
Cytomegalovirus in haematopoietic cell transplantation - The troll is still there
Allogeneic “Off-the-Shelf” CAR T cells: Challenges and advances
Interfering with KIR and NKG2A immune checkpoint axes to unleash NK cell immunotherapy
Celebrating the registration of 9.000 patients treated with CAR T cells in the EBMT registry: Collection of real-world data in the context of hematopoietic cellular therapies
The most frequent HLA alleles around the world: A fundamental synopsis
HLA-DM and HLA-DO interplay for the peptide editing of HLA class II in healthy tissues and leukemia
HLA typing: A review of methodologies and clinical impact on haematopoietic cell transplantation
Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment
The role of randomized controlled trials, registries, observational databases in evaluating new interventions
What is relative survival and what is its role in haematology?
Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults
Dysregulation of Protein S in COVID-19
Considerations to comprehensive care for the older individual with myelofibrosis
Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage
Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome
Molecular markers in ALL: Clinical implications
Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes
Spliceosomal factor mutations and mis-splicing in MDS
Autoimmune disease in CMML-the chicken or the egg?
Venetoclax-based therapies for acute myeloid leukemia
Clonal Hematopoiesis and therapy related MDS/AML
Therapy-related myeloid neoplasms in lymphoma survivors: Reducing risks
Why and how to treat Ph-like ALL?
Management of relapsed/refractory DLBCL
GMP CAR-T cell production
CAR T cell therapy for B-cell lymphomas
EUVIMED